The World Health Organization (WHO) would like to invite all civil society representatives and partners to participate in a special webinar on the WHO guideline development process, with a focus on guidelines for the management of multidrug-resistant TB (MDR-TB). The webinar will be held on 27 February from15:00H-17:00H CET.
26 January 2018 - Countries and partners at the 142nd World Health Organization (WHO) Executive Board (EB), adopted a Resolution yesterday in support of the upcoming UN General Assembly high-level meeting (UNHLM) on tuberculosis (TB). The Resolution included a request to WHO to work with key stakeholders to develop a draft TB multisectoral accountability framework to enable the monitoring, reporting, review and actions needed for greater accountability and impact, for consideration by the 71st World Health Assembly (WHA) in May 2018 and presentation during the UNHLM on TB.
24 January 2018 - Advances in mobile technologies, network coverage and internet access have transformed the way we interact with each other. These developments create novel possibilities to improve patient care, and reduce patient and health system costs. They have the potential to advance the notion of patient-centred care, bringing it within reach of many low resource settings. The Global TB Programme of the World Health Organization (WHO), in close collaboration with the European Respiratory Society (ERS), other technical partners and national tuberculosis programme staff, is releasing a practical manual on the use of digital technologies to support TB medication adherence.
WHO leadership meets with TB civil society to strengthen engagement in accelerating the End TB response
17 January 2018 – Civil society representatives met with WHO leadership in Geneva, on 15-16 January 2018, with the aim of strengthening collaboration to end TB. WHO Director-General Dr Tedros Adhanom Ghebreyesus and Dr Tereza Kasaeva, Director of the WHO Global TB Programme, opened the meeting, and Dr Soumya Swaminathan, Deputy Director-General, Dr Ren Minghui, Assistant Director General for the Cluster for Communicable Diseases, Dr Berhard Schwartlander, Chef de Cabinet, and Dr Lucica Ditiu, Executive Director of the Stop TB Partnership all expressed support for a much closer working relationship.
WHO issues a position statement on the use of delamanid for MDR-TB following an expedited review of phase III clinical trial results
15 January 2018 – The WHO Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB), following an expedited review of the phase III randomized controlled trial results released at the 48th UNION World Conference on Lung Health in Mexico by Otsuka Pharmaceutical. "This trial is the first-ever MDR-TB treatment study of its kind to be completed and reported and its findings were thus much-awaited," said Dr Tereza Kasaeva, Director of the Global TB Programme.
17 November 2017 – Today marks a critical landmark in the fight to end tuberculosis. The Moscow Declaration to End Tuberculosis, agreed to by 75 Ministers of health, is a promise to increase multisectoral action, track process, and build accountability - signalling a long overdue global commitment to stop the death and suffering caused by this ancient killer.
30 October 2017 – Global efforts to combat tuberculosis (TB) have saved an estimated 53 million lives since 2000 and reduced the TB mortality rate by 37%, according to the Global TB Report 2017, released by WHO today. Despite these achievements, the latest picture is grim. TB remains the top infectious killer in 2016. TB is also the main cause of deaths related to antimicrobial resistance and the leading killer of people with HIV. Progress in most countries is stalling and is not fast enough to reach global targets or close persistent gaps in TB care and prevention.
53 millionlives were saved through effective diagnosis and treatment, 2000-2016.Fact sheet on tuberculosis
490 000people developed multidrug-resistant tuberculosis (MDR-TB) in the world in 2016, an additional 110 000 people with rifampicin-resistant TB also required second line treatment in 2016.Q&A on MDR-TB
2.3 billionUS dollars per year needed to fill resource gap for implementing existing TB interventions.Global TB report facts
- Detection and diagnosis
- Treatment and care
- Preventive care
- Drug-resistant TB
- TB and HIV
- Childhood TB
- Addressing needs of vulnerable populations
- Technical support to countries
- Community engagement: ENGAGE-TB
- Public-Private Mix
- Monitoring and evaluation
- Digital health
- Zoonotic TB
Who we are
News releases and features
Public call for individual patient data on treatment of rifampicin and multidrug-resistant (MDR/RR-TB) tuberculosis
Special WHO webinar for civil society and partners on the TB guidelines development
UN GENERAL ASSEMBLY HIGH-LEVEL MEETING ON ENDING TB
World TB day
World TB Day is an opportunity to raise awareness about the burden of tuberculosis (TB) worldwide and the status of TB prevention and control efforts.
Activities of the Strategic and Technical Advisory Group for TB (STAG-TB), Task Force on TB Impact Measurement, Latent TB Infection Task Force, HIV/TB Task Force and the Task Force for New Drug Policy Development.
Feature stories on TB
- Personal Stories from TB Survivors - My Journey fighting TB
- UN Leaders and partners Unite to End TB
- Ethiopia: On the road to ending tuberculosis
- All feature stories
Ending TB in the WHO regions
Emma Thompson, the British actress and Mayor of London’s TB Ambassador, speaking out on the importance of joining WHO and its partners to end tuberculosis, which kills over 4,000 people each day.